These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6635769)

  • 21. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N; Tortarolo M; Volpe E; Gonnella F; Valente A; Buonanno G
    Haematologica; 1981 Apr; 66(2):196-207. PubMed ID: 6791996
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P; Forte L; Sorrentino F; Palombi M; Papa G; Marciani MG
    Bone Marrow Transplant; 1993; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnostic value of serum ferritin in anaemias and in iron overload (author's transl)].
    Villegas A; Borque M; Del Olmo J; Espinos D
    Sangre (Barc); 1980; 25(3):347-56. PubMed ID: 7414450
    [No Abstract]   [Full Text] [Related]  

  • 25. Tandem measurements of iron and creatinine by cross injection analysis with application to urine from thalassemic patients.
    Choengchan N; Mantim T; Inpota P; Nacapricha D; Wilairat P; Jittangprasert P; Waiyawat W; Fucharoen S; Sirankpracha P; Morales NP
    Talanta; 2015 Feb; 133():52-8. PubMed ID: 25435226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Iron deficiency anaemia].
    Leporrier M; Seguin A
    Rev Prat; 2004 Jan; 54(2):217-23. PubMed ID: 15086065
    [No Abstract]   [Full Text] [Related]  

  • 27. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
    Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
    Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron status in Sicilian subjects with beta-thalassemia trait.
    Musumeci S; Romeo MA; Di Gregorio F; Testa R; Schiliro' G
    Haematologica; 1985; 70(1):1-5. PubMed ID: 3924751
    [No Abstract]   [Full Text] [Related]  

  • 30. Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up.
    Miniero R; Tardivo I; Roetto A; De Gobbi M
    Pediatr Hematol Oncol; 2005 Mar; 22(2):163-6. PubMed ID: 15805002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of 2,3-dihydroxybenzoic acid (2,3-DHB) on the elimination of iron in a patient with beta-thalassemia major].
    Jensen M; Bender Ch
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):587. PubMed ID: 876248
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of ascorbic acid and citric acid on iron bioavailability in an in vitro digestion/ Caco-2 cell culture model].
    Lei J; Zhang MQ; Huang CY; Bai L; He ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1743-7. PubMed ID: 18971162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urine iron: comparative evaluation between a colorimetric method and atomic absorption spectrophotometry].
    Galdo Capotorti M; Toscano G; Pinto L
    Pediatria (Napoli); 1983; 91(4):397-402. PubMed ID: 6545403
    [No Abstract]   [Full Text] [Related]  

  • 34. A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers.
    Colpo E; de Bem AF; Pieniz S; Schettert SD; dos Santos RM; Farias IL; Bertoncello I; Moreira CM; Barbosa NV; Moretto MB; Rocha JB
    Ann Nutr Metab; 2008; 53(2):79-85. PubMed ID: 18852484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Echocardiographic measurements in transfused thalassemic major children].
    Balducci G; Antonelli GF; Mautone A; Di Lecce A; Schettini F
    Minerva Pediatr; 1980 May; 32(9):583-7. PubMed ID: 7464753
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relation between serum ferritin and various indices of hepato-cellular damage in homozygous beta-thalassemia].
    Ferrara M; Esposito L; Ponte G; Basilicata A; D'Alessandro R; De Bellis G
    Pediatria (Napoli); 1980 Dec; 88(4):561-70. PubMed ID: 7290820
    [No Abstract]   [Full Text] [Related]  

  • 37. Domestic drinking water--an effective way to prevent anemia among low socioeconomic families in Brazil.
    Dutra-de-Oliveira JE; de Almeida CA
    Food Nutr Bull; 2002 Sep; 23(3 Suppl):213-6. PubMed ID: 12362799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
    Wali YA; Taqi A; Deghaidi A
    Pediatr Hematol Oncol; 2004; 21(5):453-60. PubMed ID: 15205089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
    Flynn DM; Hoffbrand AV; Politis D
    Birth Defects Orig Artic Ser; 1982; 18(7):347-53. PubMed ID: 6819017
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    Ambruso DR; Mahony BS; Githens JH; Rhoades ED
    Am J Pediatr Hematol Oncol; 1982; 4(2):115-23. PubMed ID: 7114394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.